Lee Frank D.
- SEC CIK
- 0001814686
Latest role at each company
- BHC Bausch Health Companies Inc.Directoras of May 26, 2026
- PCRX Pacira BioSciences, Inc.Chief Executive Officeras of Feb 13, 2026
- BOLT Bolt Biotherapeutics, Inc.Directoras of Jun 14, 2024
- CIK 0001538927President and CEOas of Oct 14, 2022
Trades
Every Form 4 that lists Lee Frank D. as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| BHCBausch Health Companies Inc. | May 20, 2026 | May 19, 2026 | Lee Frank D.Director | SSaleCommon Shares, No Par Value | −24.46K | $5.43 | −$132.8K | 49.34K | −33.1% | SEC10b5-1 |
| BHCBausch Health Companies Inc. | Aug 22, 2025 | Aug 21, 2025 | Lee Frank D.Director | SSaleCommon Shares, No Par Value | −15.91K | $7.66 | −$121.89K | 73.8K | −17.7% | SEC |
| PCRXPacira BioSciences, Inc. | Aug 13, 2024 | Aug 12, 2024 | Lee Frank D.Chief Executive Officer | PPurchaseCommon Stock | +8.26K | $12.10 | +$99.99K | 107.78K | +8.3% | SEC |
| – | Feb 25, 2022 | Feb 23, 2022 | Lee Frank D.President and CEO | SSaleCommon Stock | −17.98K | $9.78 | −$175.85K | 79.77K | −18.4% | SEC |